Not Tagged
Not Tagged
['prothena']
today we presented data from the phase 3 vital study at #ash22 for patients with al #amyloidosis. we are encouraged by the results of this analysis and the potential impact on the amyloidosis patient community. 
Prothena Corp. plc is a late-stage clinical company with expertise in protein dysregulation; pipeline in rare peripheral amyloid and neurodegenerative diseases